Intravenous ibandronate in the treatment of osteoporosis: profile report.
Croom
Katherine F
KF
Wolters Kluwer Health/Adis, Auckland, New Zealand. demail@adis.co.nz
Scott
Lesley J
LJ
D015519:Bone Density / Q000187:drug effects; D004164:Diphosphonates / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D000077557:Ibandronic Acid; D007275:Injections, Intravenous; D010024:Osteoporosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology
D004164:Diphosphonates; D000077557:Ibandronic Acid